Poland – Pharmaceutical products – Successive deliveries of the medicinal product Defitelio for the Maria Skłodowska-Curie National Research Institute of Oncology – National Research Institute, Gliwice Branch
1. Successive deliveries of the medicinal product Defitelio for the Maria Skłodowska-Curie National Research Institute of Oncology – National Research Institute, Gliwice Branch 2. Procurement procedure: single-source procurement Legal basis: Article
Opportunity description
1. Successive deliveries of the medicinal product Defitelio for the Maria Skłodowska-Curie National Research Institute of Oncology – National Research Institute, Gliwice Branch 2. Procurement procedure: single-source procurement Legal basis: Article 214(1)(5) of the PPL Act. 3. Planned performance period: successively for a period of 12 months from the date of conclusion of the contract or until the earlier exhaustion of the Contracting Authority's financial limit for performance of the contract specified in § 3(1) of the contract. The contract expires upon exhaustion of the nominal contract amount or upon the end of the period for which it was concluded, whichever occurs first. 4. The Contracting Authority invited the following Contractor to negotiations: Komtur Polska Sp. z o.o., Plac Farmacji 1, 02-699 Warszawa e-mail: zp@komtur.com Successive deliveries of the medicinal product Defitelio for the Maria Skłodowska-Curie National Research Institute of Oncology – National Research Institute, Gliwice Branch Procedure: neg-wo-call. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.